People undergoing chemotherapy often blame their forgetfulness and mental sluggishness on what's called"chemo brain." New research finds no link in older breast cancer patients.

As with all of medicine these days, researchers are now finding that cancer screenings need to be personalized. Your screening schedules should be based on your family history.

Aggressive HER-2 positive metastatic breast cancer is difficult to treat. A recent study shows dual medication therapy offers new treatment options - and hope.

Older women diagnosed with breast cancer often have other health problems which can affect their overall survival. So it's important for primary care physicians to work with oncologists to treat the whole woman.

Just like a good bra, one size definitely does not fit all when it comes to considering when to begin mammograms. In another step toward personalized healthcare, a new study suggests standards should be modified regarding when to begin mammograms.

In an unprecedented appeals hearing, the US Food and Drug Administration (FDA) has not changed its mind.  An FDA panel voted that the drug Avastin no longer be approved for treating late-stage breast cancers.

Radiation following mastectomies is not usually recommended, except for patients with advanced or high-risk breast cancers. Yet most of these patients aren't receiving this potentially lifesaving treatment.

Even though a U.S. Food and Drug Administration (FDA) panel has voted to no longer approve Avastin ( bevacizumab ) for treating late-stage breast cancers, Medicare has indicated it will continue to pay for the drug.

In a first ever hearing, the U.S. Food and Drug Administration is considering reversing itself on a ruling to withdraw Avastin as a drug to treat metastatic (spread outside of the primary affected organ) breast cancer.

Women can reduce their risks of developing breast cancer with lifestyle changes. Scientists now know just how much those changes impact overall risks in both individuals and populations at large.